tiprankstipranks
Monte Rosa Therapeutics (GLUE)
NASDAQ:GLUE
US Market

Monte Rosa Therapeutics (GLUE) Stock Investors

198 Followers
Based on 747,528 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold GLUE
On average, investors allocate 0.00% of their portfolios to GLUE
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 747,528 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding GLUE

4.2%
Last 7
Days
187.4%
Last 30
Days
Percentages indicate the change in the number of portfolios holding GLUE, out of 747,528 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

GLUE Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.22%
$6.70
Increased
6.00%
$4.74
Increased
0.18%
$3.95
Increased
<0.01%
$3.89
Increased
10.22%
$4.87
Increased
0.09%
$3.89
Based on the activity of 14,193 investors who made their portfolios public
The table shows changes in GLUE in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

GLUE Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Caterpillar
4.39%
+1.02%
+1.46%
170.01B
Industrials
Raytheon Technologies
4.04%
-1.17%
-1.61%
136.69B
Industrials
Delta Air Lines
5.26%
-0.38%
+2.22%
29.33B
Industrials
Riot Platforms
5.15%
-0.53%
+0.54%
3.47B
Financial
Zscaler
3.82%
-1.05%
+1.72%
28.50B
Technology
DraftKings
5.81%
-1.48%
-2.00%
32.41B
Consumer Cyclical
Micron
5.49%
+1.19%
+18.49%
126.70B
Technology
Microstrategy
7.07%
+1.56%
+7.77%
31.55B
Technology
ServiceNow
3.89%
-1.25%
+0.17%
154.00B
Technology
UiPath
3.29%
-1.66%
-2.81%
6.90B
Technology
Based on the activity of 747,528 active portfolios
Open your Smart Portfolio

GLUE Investor Analysis

GLUE investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
18.2%
of GLUE holders
are under 35
Average Segment Performance
Average P/E Ratio20.77
Beta7.15
Dividend Yield6.79%
GLUE investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
45.5%
of GLUE holders
are between 35–55
Average Segment Performance
Average P/E Ratio19.59
Beta11.22
Dividend Yield6.44%
GLUE investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
36.4%
of GLUE holders
are over 55
Average Segment Performance
Average P/E Ratio19.41
Beta3.84
Dividend Yield7.80%
Overview of age group and performance of GLUE stock investors
See who invests in GLUE according to age group and performance.

FAQ

How many retail Investors hold GLUE?
<0.1% of TipRanks' retail investors hold GLUE in their portfolios.
    What is GLUE Investor Sentiment?
    GLUE’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of GLUE in the last 7 days?
      ▲ 4.2% of TipRanks' retail investors changed their holding of GLUE in the last 7 days.
        What percentage of retail investors changed their holding of GLUE in the last 30 days?
        ▲ 187.4% of TipRanks' retail investors changed their holding of GLUE in the last 30 days.
          What is the average age of retail investors who hold GLUE?
          The average age of GLUE Holders is between 35–55.
            What other stocks have GLUE investors also bought?
            GLUE Investors also bought CAT, RTX, DAL, RIOT, ZS, DKNG, MU, MSTR, NOW, PATH.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALNYAlnylam Pharma
              BCRXBioCryst
              CYTKCytokinetics
              DHRDanaher
              EWEdwards Lifesciences
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis